Document is current
Any future updates will be listed below
-
Authors
D’Arcy, Monica
Fleming, Jodie
Robinson, Whitney R.
Kirk, Erin L.
Perou, Charles M.
Troester, Melissa A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (5 R25 CA057726-23)
National Institutes of Health (R21 CA175783)
National Institutes of Health (U01 CA 179715)
National Institutes of Health (U01 ES 019472)
National Institutes of Health (P50 CA058223)
National Institutes of Health (R21 CA175783)
National Institutes of Health (U54 CA156735)
National Institutes of Health (U54 CA156735)
National Institutes of Health (K01CA172717)
- License Information
-
More Information
Article History
Received: 2 March 2015
Accepted: 15 June 2015
First Online: 25 June 2015
Compliance with ethical standard
:
: C.M.P is an equity stock holder, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. C.M.P is also listed an inventor on a patent application for the PAM50 assay.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
